FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 84 filers reported holding FORTRESS BIOTECH INC in Q4 2021. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $24,464 | -32.9% | 44,480 | 0.0% | 0.00% | – |
| Q1 2023 | $36,474 | +25.2% | 44,480 | 0.0% | 0.00% | – |
| Q4 2022 | $29,134 | -23.3% | 44,480 | 0.0% | 0.00% | – |
| Q3 2022 | $38,000 | +18.8% | 44,480 | +17.6% | 0.00% | – |
| Q2 2022 | $32,000 | -37.3% | 37,814 | 0.0% | 0.00% | – |
| Q1 2022 | $51,000 | -46.3% | 37,814 | 0.0% | 0.00% | – |
| Q4 2021 | $95,000 | -22.1% | 37,814 | 0.0% | 0.00% | – |
| Q3 2021 | $122,000 | -9.6% | 37,814 | 0.0% | 0.00% | – |
| Q2 2021 | $135,000 | +1.5% | 37,814 | 0.0% | 0.00% | – |
| Q1 2021 | $133,000 | +10.8% | 37,814 | 0.0% | 0.00% | – |
| Q4 2020 | $120,000 | -35.8% | 37,814 | -18.3% | 0.00% | – |
| Q3 2020 | $187,000 | +85.1% | 46,272 | +22.4% | 0.00% | – |
| Q2 2020 | $101,000 | +42.3% | 37,814 | 0.0% | 0.00% | – |
| Q1 2020 | $71,000 | – | 37,814 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,000,000 | $580,600 | 0.19% |
| Nantahala Capital Management | 6,018,211 | $1,747,087 | 0.15% |
| THOMPSON DAVIS & CO., INC. | 12,996 | $3,773 | 0.01% |
| Platform Technology Partners | 30,000 | $8,709 | 0.00% |
| Black Maple Capital Management LP | 15,000 | $4,355 | 0.00% |
| Arete Wealth Advisors, LLC | 52,547 | $15,254 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 144,700 | $42,006 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 1,075,531 | $311 | 0.00% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 1,542,000 | $447,643 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,000 | $581 | 0.00% |